Literature DB >> 3042051

Gene products which play a role in cancer invasion and metastasis.

L A Liotta1.   

Abstract

Invasion requires a number of distinct tumor cell interactions with host tissue, beginning with attachment to the matrix, followed by hydrolysis of matrix material and locomotion. Gene products which may be involved in these steps are discussed here. Laminin receptors and integrins have roles in the adhesion phase, while certain collagenases are prominent among the matrix-degrading enzymes. Autocrine motility factors, distinct from growth factors, appear to be involved in tumor cell locomotion. Finally, certain oncogenes, particularly of the ras family, are closely related with metastatic potential. A detailed understanding of the molecular biology of invasion and metastasis could ultimately lead to specific means of interfering with or even reversing these malignant processes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3042051     DOI: 10.1007/BF01805835

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  59 in total

1.  Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells.

Authors:  S E Egan; G A McClarty; L Jarolim; J A Wright; I Spiro; G Hager; A H Greenberg
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

Review 2.  Integrins: a family of cell surface receptors.

Authors:  R O Hynes
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

3.  The tumor promoter phorbol 12-myristate 13-acetate induces a program of altered gene expression similar to that induced by platelet-derived growth factor and transforming oncogenes.

Authors:  M S Rabin; P J Doherty; M M Gottesman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

4.  Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations.

Authors:  S Sukumar; V Notario; D Martin-Zanca; M Barbacid
Journal:  Nature       Date:  1983 Dec 15-21       Impact factor: 49.962

5.  ras-transformed cells: altered levels of phosphatidylinositol-4,5-bisphosphate and catabolites.

Authors:  L F Fleischman; S B Chahwala; L Cantley
Journal:  Science       Date:  1986-01-24       Impact factor: 47.728

6.  Human small-cell lung cancers show amplification and expression of the N-myc gene.

Authors:  M M Nau; B J Brooks; D N Carney; A F Gazdar; J F Battey; E A Sausville; J D Minna
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

7.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.

Authors:  G M Brodeur; R C Seeger; M Schwab; H E Varmus; J M Bishop
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

8.  Proto-oncogene abnormalities in human breast cancer: correlations with anatomic features and clinical course of disease.

Authors:  M J Cline; H Battifora; J Yokota
Journal:  J Clin Oncol       Date:  1987-07       Impact factor: 44.544

9.  Karyotypic analysis of diploid or near diploid metastatic Harvey ras transformed rat embryo fibroblasts.

Authors:  R J Muschel; K Nakahara; E Chu; R Pozzatti; L A Liotta
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

10.  Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.

Authors:  P H Hand; V Vilasi; A Thor; N Ohuchi; J Schlom
Journal:  J Natl Cancer Inst       Date:  1987-07       Impact factor: 13.506

View more
  12 in total

Review 1.  Biological response modifiers in the management of patients with breast cancer.

Authors:  D L Longo; L C Hartmann
Journal:  Breast Cancer Res Treat       Date:  1990-09       Impact factor: 4.872

2.  Positive and negative transcriptional elements of the human type IV collagenase gene.

Authors:  S M Frisch; J H Morisaki
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

3.  Activated leukocyte cell adhesion molecule (ALCAM) and annexin II are involved in the metastatic progression of tumor cells after chemotherapy with Adriamycin.

Authors:  S Choi; M Kobayashi; J Wang; H Habelhah; F Okada; J Hamada; T Moriuchi; Y Totsuka; M Hosokawa
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  Elevated levels of annexin I protein in vitro and in vivo in rat and human mammary adenocarcinoma.

Authors:  S D Pencil; M Toth
Journal:  Clin Exp Metastasis       Date:  1998-02       Impact factor: 5.150

5.  Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue.

Authors:  C Monteagudo; M J Merino; J San-Juan; L A Liotta; W G Stetler-Stevenson
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

6.  Cathepsin-D expression in cervical carcinoma and its prognostic significance.

Authors:  K M Mitchell; R J Hale; C H Buckley; H Fox; D Smith
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

7.  The N-Myc down regulated Gene1 (NDRG1) Is a Rab4a effector involved in vesicular recycling of E-cadherin.

Authors:  Sushant K Kachhap; Dennis Faith; David Z Qian; Shabana Shabbeer; Nathan L Galloway; Roberto Pili; Samuel R Denmeade; Angelo M DeMarzo; Michael A Carducci
Journal:  PLoS One       Date:  2007-09-05       Impact factor: 3.240

8.  Inhibitory effects of malotilate on invasion and metastasis of rat mammary carcinoma cells by modifying the functions of vascular endothelial cells.

Authors:  H Nagayasu; J Hamada; T Kawano; S Konaka; D Nakata; T Shibata; M Arisue; M Hosokawa; N Takeichi; T Moriuchi
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

9.  Expression of pepsinogen C in human breast tumours and correlation with clinicopathologic parameters.

Authors:  I Diez-Itza; A M Merino; J Tolivia; F Vizoso; L M Sánchez; C López-Otín
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

10.  Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells.

Authors:  H Niizeki; M Kobayashi; I Horiuchi; N Akakura; J Chen; J Wang; J-i Hamada; P Seth; H Katoh; H Watanabe; A Raz; M Hosokawa
Journal:  Br J Cancer       Date:  2002-06-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.